The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.
By Salvatore Mottillo, K. Filion, J. Genest, L. Joseph, L. Pilote, P. Poirier, S. Rinfret, E. Schiffrin, M. Eisenberg. Journal of the American College of Cardiology, 2010
2,806 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/88d5fb953f440a807e92db69c659ff4a15fc747c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- Metabolic syndrome: definitions and controversies (2011, neutral): “5-fold increase in all-cause mortality [40].”
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011, background): “5-fold increase in all-cause mortality.(168) How to capture the extra risk beyond the traditional risk factors in clinical practice is a debated issue; even the definition of MetS is not fully harmonized.”
- Pathophysiology of human visceral obesity: an update. (2013, background): “For the time being, although meta-analyses have shown that metabolic syndrome increases relative risk of type 2 diabetes and CVD (154, 173, 177, 382), it cannot be used as a CVD risk estimate but rather as a tool to emphasize the need to target excess abdominal adiposity by proper lifestyle habits (”
- Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training (2013, neutral): “58) mortality in subjects with MS (454).”
- Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile (2013, background): “For instance, the 81% increased risk for cardiovascular disease onset is very similar to that observed for well-established risk factors, such as obesity [6], metabolic syndrome [7], low high-density lipoprotein (HDL) cholesterol [8] or high C-reactive protein (CRP) [9].”